Assumed rivaroxaban–standard anticoagulation hazard ratio | Assumed 95% CI if incidence of the main efficacy outcome is 2.0% on standard anticoagulationa | Assumed 95% CI if incidence of the secondary efficacy outcome is 10% on standard anticoagulationa |
---|---|---|
0.500 | 0.11–2.28 | 0.25–0.99 |
0.667 | 0.16–2.76 | 0.35–1.26 |
0.800 | 0.20–3.14 | 0.43–1.48 |
0.930 | 0.25–3.52 | 0.51–1.69 |
1.000 | 0.27–3.72 | 0.56–1.80 |
1.075 | 0.29–3.94 | 0.60–1.92 |
1.250 | 0.35–4.45 | 0.71–2.21 |
1.500 | 0.43–5.18 | 0.86–2.61 |
2.000 | 0.60–6.64 | 1.17–3.42 |